Quantcast

Saint Pete MRI Brings Sapheneia Dose Reduction Technology to the Greater Tampa / St. Petersburg Metropolitan Area

January 10, 2014

CT radiation dose is a concern shared by clinicians, patients and medical imaging providers across the nation.

St. Petersburg, Florida (PRWEB) January 10, 2014

Saint Pete MRI is leading the charge to lower dose in its outpatient imaging center in the greater Tampa / St. Petersburg metropolitan area. Following a national search for the best CT solution, Saint Pete MRI chose the Sapheneia, Clarity CT Solution to be installed on their Phillips MX8000 16-Slice CT Scanner. The Sapheneia Solution provides image optimization which enables the lowest radiation dose, while maintaining the highest diagnostic image quality.

ABOUT SAINT PETE MRI

Saint Pete MRI has been providing quality patient care through state of the art diagnostic imaging in the Tampa Bay area for over 16 years. We are committed to providing high quality diagnostic imaging services to patients and referring physicians and will provide the solution to meet your requirements.

For more information visit, http://www.saintpetemri.com.

ABOUT SAPHENEIA INC.

Sapheneia, Inc. (“Sapheneia”) is an American global imaging services and scientific based technologies company that specializes in diagnostic and analytical image processing solutions among other innovative products. The solutions provided by Sapheneia, range from dose reduction services for X-Ray and CT to improved MRI workflow. Sapheneia was founded in 2006 and utilizes the best imaging engineering worldwide through its Swedish office. It is the first non-Original Equipment Manufacturer (OEM) company created and dedicated to radiation dose reduction through image quality enhancement. Sapheneia provides medical image optimization products that promote higher diagnostic confidence, greater patient and medical staff safety, and improves medical imaging cost effectiveness.

For more information visit, http://www.sapheneia.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/01/prweb11474119.htm


Source: prweb



comments powered by Disqus